1
Return

Chimeric antigen receptor therapy for hepatocellular carcinoma

delete2026-03-10
delete0
PRE
AI
L
Lorenz Kocheise
M
Mohamed-Reda Benmebarek
M
Mitchell Ho
T
Tim F. Greten *
DOI：10.1016/j.smim.2025.102000delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
• This review summarizes the current landscape of cellular therapies for HCC. • CAR-based cellular therapies show strong potential for treating hepatocellular carcinoma. • The liver's unique microenvironment distinguishes HCC from other cancer types. • Liver-specific strategies may enhance the efficacy of CAR therapies for HCC.
Keywords:
CAR therapy
hepatocellular carcinoma
cellular therapy
liver microenvironment
liver-specific strategies

Journal

Seminars in Immunology cover
Seminars in Immunology
IF:
7.8
Papers:
1.5K
Citations:
7.3K

Organization

N
national institutes of health
Scholars:
2.8K
Papers: 802
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers